OTC Supplement May Reduce Brain Atrophy in SPMS - Medscape, 9/25/16 - "The small, 51-patient pilot trial showed that those randomly assigned to 1200 mg of lipoic acid daily had a significantly lower annualized rate of whole-brain atrophy at 96 weeks, as measured by MRI, than the participants who were assigned to matching placebo ... At 96 weeks, the group receiving placebo had a whole-brain atrophy rate of 0.65% per year, "which is comparable to rates in other progressive MS natural history cohorts," ... On the other hand, use of lipoic acid resulted in a significantly lower annualized atrophy rate of 0.22%, which represented a 66% reduction vs placebo" - See alpha lipoic acid products at Amazon.com and alpha lipoic acid at iHerb.
Doctor's Best Stabilized R-Lipoic Acid with BioEnhanced Na-RALA 100mg 60 veggie caps
